Mer

Home / BMD®

BMD®

BMD® is a Type A Medicated Article for the prevention and control of necrotic enteritis, increased rate of weight gain and improved feed efficiency in poultry. BMD contains feed grade bacitracin methylene disalicylate equivalent to 100 grams (10%) bacitracin per kg of premix

IMPORTANT NOTICE!

Please note that this is a general product information according to US approvals, for specific regulatory information concerning your market please contact Regulatory department email: Regulatory.AffairsMER@zoetis.com

Close

Expand All
  • Indications for Use

    • Aids in the prevention and control of necrotic enteritis in chickens caused or complicated by Clostridium spp. and as an aid in the control of transmissible enteritis in growing turkeys

    • For prevention of ulcerative enteritis in quail caused by Clostridium colinum

    • For increased rate of weight gain and improved feed efficiency in chickens, turkeys, pheasants and quail

    • For increased egg production and improved feed efficiency in laying hens during the first seven months of production

  • Features and Benefits

    • By controlling necrotic enteritis, BMD preserves the integrity of the gut wall, helping to ensure the absorption of nutrients from feed1

    • Not absorbed from the intestinal tract, thus no withdrawal period needed2

    • Patented Chilsonation process produces free-flowability, dust-free granules to improve fl owability and stability to ensure proper dosage

    • Reduces subclinical and clinical disease, resulting in greater productivity and decreased morbidity/mortality

    • Consistent performance after many years of use

    • BMD is not included in the FDA/CVM list of medically important antibiotics for human health3

  • FDA Status

    • Category I drug and does not require a feedmill license for manufacture of medicated feeds

    • Approved for use in combination with Avatec®, Deccox®, Robenz®and Zoamix®

    *Reference Title 21 Code of Federal Regulations 558.76 for species-specific combination clearances.

  • Storage and Packaging

    • Store in a protected location, avoid excessive heat and keep package closed to avoid contamination

    • BMD is packaged in a 25 kg, multiwall paper bag with protective barrier ply

  • Safe Handling

    • Expiration period is 30 months from the date of manufacture (package indicates expiration date)

    • For use in the manufacture of medicated animal feeds

    • For use in dry feeds only

    • Not for use in Liquid Type B Medicated Feeds

  • Dosage and Administration

    Active Drug Ingredient

    Each kilogram contains feed grade bacitracin methylene disalicylate equivalent to 100 grams bacitracin (Master Standard).

    Composition

    A dried precipitated fermentation product obtained by culturing B. licheniformis Tracy on media adapted for microbiological production of bacitracin; calcium carbonate.

    Species

    Grams Bacitracin Per Ton of Feed

    Indications for Use

    Broiler and Replacement Chickens

    4.4 – 55

    55

    For increased rate of weight gain and improved feed efficiency.

    As an aid in prevention of necrotic enteritis caused or complicated by Clostridium spp. or other organisms susceptible to bacitracin methylene disalicylate.

     

    110 – 220

    As an aid in control of necrotic enteritis caused or complicated by Clostridium spp. or other organisms susceptible to bacitracin methylene disalicylate.

     

     

    CAUTION: To control a necrotic enteritis outbreak, start medication at the first clinical signs of disease. The dosage range permitted provides for different levels based on severity of the infection. Consult a poultry diagnostic laboratory or pathologist to determine the diagnosis and advice regarding the optimal level of drug. Administer continuously for 5 to 7 days or as long as clinical signs persist, then reduce medication to prevention level (50 g/ton).

    Laying Hens

    11 – 27.5

    For increased egg production and improved feed efficiency during the first seven months of production

    Note: Where minimum levels are shown, increase the antibiotic concentration within approved range when necessary to fit the feeding program, and to insure adequate levels of antibiotic in the complete ration.

    For Use in Animals Only.

    For Use in Dry Feeds Only.

    >Not for Use in Liquid Type B Medicated Feeds.

    NADA 46-592, Approved by FDA

1 Miller SH, Skinner J, Davis SW. Efficacy of Probiotic and/or BMD® in the Feed for Control of Necrotic Enteritis Caused by Clostridium perfringens in Broiler Chickens. Zoetis Inc. Data on file.

2 Original New Animal Drug Application (Bacitracin methylene disalicylate—BMD®). NADA 141-153. Food and Drug Administration, Center for Veterinary Medicine, January 13, 2000.

3 FDA Guidance for Industry #152. Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern. Food and Drug Administration, Center for Veterinary Medicine, October 23, 2003.

Avatec, BMD, Deccox, Robenz and Zoamix are registered trademarks of Zoetis Products, LLC, a subsidiary of Zoetis Inc. ©2013 Zoetis Inc. All rights reserved. BMD is manufactured and distributed by Zoetis Products, LLC; contact your Zoetis representative for product availability. ZP130018